Chemomab Therapeutics Ltd. (CMMB)
Nasdaq: CMMB · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2011
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Report filed | Mar 23, 2026 | Apr 4, 2025 | Mar 28, 2024 | Mar 20, 2023 | Mar 30, 2022 | Mar 9, 2021 | Mar 17, 2020 | Mar 25, 2019 |
| Cost of revenue | 2,326 | 2,465 | 4,393 | 5,142 | 3,310 | · | · | · |
| Research and development | 5,833 | 11,327 | 18,381 | 16,977 | 6,334 | 4,684r | 13,303 | 7,514 |
| General and administrative | 3,734 | 3,412 | 7,078 | 11,556 | 6,033 | 1,288r | 6,245 | 5,521 |
| Total operating expenses | 9,567 | 14,739 | 25,459 | 28,533 | 12,367 | 5,972r | 22,898 | 13,035 |
| Operating income | -112,000 | -103,000 | · | · | · | · | · | · |
| Total non-operating income (expense) | 572 | 794 | 1,238 | 353 | -111 | · | · | · |
| Income before income taxes | -8,995 | -13,945 | -24,221 | -28,180 | -12,478r | 5,951r | 27,124 | 13,492 |
| Income tax expense | 0 | 0 | 0 | -534 | 0 | 0 | 0 | 306 |
| Net income including non-controlling interests | -8,995 | -13,945 | -24,221 | -27,646 | -12,478 | -5,951r | -27,124 | -13,798 |
| Net income | -8,995 | -13,945 | -24,221 | -27,646 | -12,478 | -5,951r | -27,124 | -13,798 |
| Earnings per share, basic | 0.018 | 0.039 | 0.103 | 0.121 | 0.06 | · | · | · |
| Earnings per share, diluted | 0.018 | 0.039 | 0.103 | 0.121 | 0.06 | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | 0.06 | 0.044r | 0.79 | 1.09 |
| Weighted average shares, basic | 510,227,715 | 359,048,638 | 234,998,859 | 227,589,288 | 207,468,650 | · | · | · |
| Weighted average shares, diluted | 510,227,715 | 359,048,638 | 234,998,859 | 227,589,288 | 207,468,650 | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 207,468,650 | 136,755,498r | 34,446r | 12,634,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Cost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted